WHITEPAPER - Case Study-Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening
Abstract: A team of bioavailability experts at Catalent used the in-house bioavailability enhancement platform, OptiForm® Solution Suite, to optimize and develop Phase 1 clinical formulation within a short timeline. Catalent’s global supply chain expertise was utilized for packaging and distributing clinical supplies to the site and, as a result, the target molecule went from early stage to Phase 1 in under 9 months. Download the whitepaper to learn more!
Learn More About:
- Only 30g of drug substance was used and provided candidate formulation for toxicology studies in only 12 weeks
- Two spray dry dispersions were developed; both showed equivalent bioavailability but one showed better PK
- A finished dose capsule using the chosen spray dispersion was packaged and distributed to clinical sites
Total Page Views: 1988
